BASIS~ (603) 893-3758

Whitepaper: Nitrosamines Analysis

WHITEPAPERS Home / Whitepapers / Nitrosamines Analysis Nitrosamines Analysis Since the FDA’s discovery of nitrosamines impurities, which led to the voluntary recall of valsartan in 2018, the pharmaceutical industry has undertaken a thorough investigation of this class...